Terry discusses his bone marrow stem cell treatment from Dr Harry Adelson for spine pain
Terry discusses his bone marrow stem cell treatment from Dr Harry Adelson for spine pain. After 30 years of low back pain, one treatment from Dr Adelson with...
By: Harry Adelson
Read more here:
Terry discusses his bone marrow stem cell treatment from Dr Harry Adelson for spine pain - Video
Orange County, California (PRWEB) December 23, 2013
The top stem cell therapy clinic in California, TeleHealth, is now offering PRP therapy for hip arthritis. The treatments are often able to delay or avoid the need for joint replacement, and are administered by Board Certified doctors at two clinic locations. Call (888) 828-4575 for more information and scheduling.
Tens of millions of Americans suffer from hip arthritis, and hundreds of thousands of hip replacements are performed every year. Nonoperative treatments prior to joint replacement often consist of steroid injections for pain relief. While the joint replacement typically has excellent pain relief outcomes, there are risks involved and sometimes the eventual need for a revision procedure.
Therefore, a procedure that offers pain relief while offering the potential for joint repair is a welcome option in hip arthritis management. TeleHealth is now offering platelet rich plasma therapy, known as PRP therapy for short, to provide pain relief and potential joint regeneration. The procedure involves a simple blood draw at the office, with the blood then being spun down in a centrifuge to obtain a solution of concentrated platelets and growth factors.
The PRP is then injected into the symptomatic hip, providing an immense amount of regenerative medicine to the arthritic joint. The material then calls in the body's stem cells as well. Published studies on PRP for joint arthritis have so far shown excellent results for pain relief.
Often times, PRP therapy at TeleHealth is covered by insurance. Verification by the clinic is able to check prior to the procedure. Patients are seen from all over Southern California for treatment of hip, knee and shoulder arthritis along with tendonitis and ligament injury. This often includes athletes, weekend warriors, executives, senior citizens and more.
To receive further information on stem cell and PRP therapy for joint arthritis or soft tissue injury, call (888) 828-4575.
Read more:
West Coast Stem Cell Clinic, TeleHealth, Now Offering PRP Therapy for Hip Arthritis Treatment
Adult stem cells circulate throughout our bodies and act as natural healers. These cells have vast potential and limitless capabilities. For more than 40 years, adult stem cells have been used to treat cancer patients. Recent advancements in stem cell therapy have been astounding. Cells from an ill patient are being used as part of the treatment. There is no possibility of the body rejecting the new tissue formed, making stem cell treatment safe and effective in achieving positive medical outcomes. It is important to note that adult stem cell therapy is not controversial because it involves the use of a patients owntissues and NOT derived from embryos. Clinical results from cardiac, pulmonary, neurological and vascular procedures have shown that the adult stem cell procedures are as safe as traditional procedures and are complimentary to current medical practice.
Adult stem cells are extracted from the patientsbone marrow and fat(adipose). At Intercellular Sciences, the naturally occurring stem cells in the blood are cultivated into millions of RegenocyteAdult Stem Cells. The Regenocyte Stem Cells areproduced inour international treatment center and are administered into the area of need for the patient. Once injected, they stimulate tissue re-growth and greater blood flow to the affected areas. The goal of the treatment is to replace damaged cells and to promote the growth of new blood vessels and tissues in order to help the target organ function at a greater capacity. There is no risk of rejection since the Adult Stem Cells received are directly from the patient.
Regenocyte Adult Stem Cell Therapy is safe, highly effective and presents minimal risk.
To find out more today, click here or call us at (866) 216-5710
Excerpt from:
Adult Stem Cell Therapy - Regenocyte
Florida Hospital Pepin Heart Institute is First in West & Central Florida to Perform a Groundbreaking Stem Cell Clinical Trial for Heart Failure Patients
The first patient has been treated as part of The ATHENA Trial, which derives stem cells from the patientsown adipose (fat) tissue and injects extracted cells into damaged parts of the heart.
TAMPA, Florida (December 20, 2013) Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute announced the first patient, a 59 year old Clearwater man, has been treated as part of the ATHENA clinical trial. The trial, sponsored by San Diego-based Cytori Therapeutics, derives stem cells from the patients own fat tissue and injects extracted cells into damaged parts of the heart. The ATHENA trial is a treatment for chronic heart failure due to coronary heart disease. Dr. Charles Lambert, Medical Director of Florida Hospital Pepin Heart Institute, is leading the way for the first U.S. FDA approved clinical trial using adipose-derived regenerative cells, known as ADRCs, in chronic heart failure patients. I am pleased to report that all procedures went well. The patient is doing well, he was released and is recovering at home. We look forward to following his progress over the coming months, said Dr. Charles Lambert. Heart failure (HF) can occur when the muscles of the heart become weakened and cannot pump blood sufficiently throughout the body. The injury is most often caused by inadequate blood flow to the heart resulting from chronic or acute cardiovascular disease, including heart attacks. The ATHENA clinical trial procedure is a three step process. First, the trial involves the collection of fat from the patients body by liposuction. Then the fat sample is filtered through a machine that extracts out the stem cells. Finally, the stem cells are injected into the damaged part of the patients heart. During this first case at Florida Hospital Pepin Heart Institute, Dr. Paul Smith performed the liposuction to obtain the fat sample, a team at the Dr. Kiran C. Patel Research Institute isolated stem cells from the fat sample and then Dr. Charles Lambert performed the cell therapy by direct injection into the patients heart. Pepin Heart and Dr. Kiran C. Patel Research Institute is exploring and conducting leading-edge research to develop break-through treatments long before they are even available in other facilities. Stem cells have the unique ability to develop into many different cell types, and in many tissues serve as an internal repair system, dividing essentially without limit to replenish other cells, said Dr. Lambert.
The Pepin Heart Institute has a history of cardiovascular stem cell research as part of the NIH sponsored Cardiac Cell Therapy Research Network (CCTRN) as well as other active cell therapy trials. The trial is a double blind, randomized, placebo controlled study designed to study the use of a patients own Adipose-Derived Regenerative Cells (ADRCs) to treat chronic heart failure from coronary heart disease in patients who are on maximal therapy and still have heart failure symptoms. All trial participants undergo a minor liposuction procedure to remove fat (adipose) tissue. Following the liposuction, trial participants may have their tissue processed with Cytoris proprietary Celution System to separate and concentrate cells, and prepare them for therapeutic use. Trial participants will then have either their own cells or a placebo injected back into their damaged heart tissue. To test whether ADRCs will improve heart function, several measurements will be made, including peak oxygen consumption (VO2max), which measures how much physical exercise (gentle walking on a treadmill) a patient can perform, blood flow to the heart (perfusion), the amount of blood in the left ventricle at the end of contraction and relaxation (end-systolic and end-diastolic volumes), and the fraction of blood that is pumped during each contraction (ejection fraction). After the injection procedure, patients are seen in the clinic for follow-up visits over the first 12 months; they are then contacted by phone once a year for up to five years after the procedure.
There are approximately 5.1 million Americans currently living with heart failure, according to the American Heart Association. Chronic heart failure due to coronary heart disease is a severe, debilitating condition caused by restriction of blood flow to the heart muscle, reducing the hearts oxygen supply and limiting its pumping function. Individuals interested in participating in the ATHENA clinical research trial or learning more can visit http://www.theathenatrial.com or call Brian Nordgren, Florida Hospital Pepin Heart Institute Physician Assistant & Stem Cell Program Lead at (813) 615-7527.
About Florida Hospital Tampa Florida Hospital Tampa is a not-for-profit 475-bed tertiary hospital specializing in cardiovascular medicine, neuroscience, orthopaedics, womens services, pediatrics, oncology, endocrinology, bariatrics, wound healing, sleep medicine and general surgery including minimally invasive and robotic-assisted procedures. Also located at Florida Hospital Tampa is the renowned Florida Hospital Pepin Heart Institute, a recognized leader in cardiovascular disease prevention, diagnosis, treatment and leading-edge research. Part of the Adventist Health System, Florida Hospital is a leading health network comprised of 22 hospitals throughout the state. For more information, visit http://www.FHTampa.org.
About Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute Florida Hospital Pepin Heart Institute is a free-standing cardiovascular institute providing comprehensive cardiovascular care with over 76,000 angioplasty procedures and 11,000 open-heart surgeries in the Tampa Bay region. Leading the way with the first accredited chest pain emergency room in Tampa Bay, the institute is among an elite few in the state of Florida chosen to perform the ground breaking Transcatheter Aortic Valve Replacement (TAVR) procedure. It is also a HeartCaring designated provider and a Larry King Cardiac Foundation Hospital. Florida Hospital Pepin Heart Institute and the Dr. Kiran C. Patel Research Institute, affiliated with the University of South Florida (USF), are exploring and conducting leading-edge research to develop break-through treatments long before they are available in most other hospitals. To learn more, visit http://www.FHPepin.org.
ends
Scoop Media
Read the original here:
Groundbreaking Stem Cell Clinical Trial
A drawback for the use of stem cells in medical treatment is their limited supply due to slow rate of growth in conventional laboratories. Dr Abba Zubair of the Cell Therapy Laboratory at Mayo Clinic in Florida believes this problem could be overcome and stem cell generation sped up by conducting the process in space. He will now have the opportunity to put his hypothesis to the test, courtesy of a US$30,000 grant that will see Zubair send human stem cells to the International Space Station (ISS) to observe whether they do in fact grow at a greater rate than on terra firma.
According to the Mayo Clinic, experiments conducted on Earth using microgravity (replication of gravitational field about 250 miles (402.3 km) from Earths surface) have shown that these conditions are more conducive to stem cell growth than conventional laboratories.
On Earth, we face many challenges in trying to grow enough stem cells to treat patients, says Zubair. It now takes a month to generate enough cells for a few patients. A clinical grade laboratory in space could provide the answer we have all been seeking for regenerative medicine.
In his laboratory in Florida, Zubair currently grows cells that induce the regeneration of neurons and blood vessels in sufferers of hemorrhagic strokes. He believes that if these cells were generated in space instead, their population would increase rapidly, allowing for treatment of a wide variety of conditions.
If you have a ready supply of these cells, you can treat almost any condition, and theoretically regenerate entire organs using a scaffold, says Zubair.
The next step for Zubair is to work with engineers at the University of Colorado to build a specialized cell bioreactor, which they hope will be taken to the ISS within a year to begin the experiment.
Dr. Zubair outlines his plans in the video below.
Source: Mayo Clinic
Read more here:
Researcher sending stem cells into space to observe rate of growth
Foetal stem cell treatment sees success in fighting brittle bone disease Channel NewsAsia
A team of experts from Singapore #39;s National University Hospital (NUH) has made a clinical breakthrough in their work on foetal stem cell treatment, after suc...
By: News
More here:
Foetal stem cell treatment sees success in fighting brittle bone disease Channel NewsAsia - Video
Poway, CA (PRWEB) December 19, 2013
Amazing Grace Hamiltons banked stem cells from Vet-Stem, Inc. have recently helped her avoid hip surgery for the second time. Gracie is now nearly 12 years old and her owners noticed her activities had dramatically slowed in the last year. They turned to banked stem cells that Gracie had stored with Vet-Stem, Inc. in Poway, California to help with the discomfort and pain of arthritis that was slowing her down.
When Gracies owners brought her to Garden State Veterinary Specialists in Tinton Falls, New Jersey in October of this year the x-rays showed a severely deteriorated right hip. Dr. Thomas Scavelli and Dr. Michael Hoelzler were very concerned and recommended hip replacement. Gracies owners wanted to try stem cell therapy first, since it had given them such positive results five years before.
We needed to give the stem cells a try before going to the more invasive surgical approach, Mrs. Hamilton said. At the time of the procedure Dr. Hoelzler told me that Gracies hips were the worst he had seen, but in just a couple of days after the stem cell therapy we began to see a difference. Just shy of two weeks after the procedure I took her back to Dr. Hoelzler and he was very impressed. She was walking comfortably.
At three years Gracie had been diagnosed with hip dysplasia. By six years of age she had slowed to the point of great concern as her owners described it. The pain caused by arthritis from the hip dysplasia was beginning to interfere with her life.
Gracie was no longer running and jumping, and certain activities had become difficult (like climbing onto my husbands sailboat). She also had a noticeable limp, Mrs. Hamilton remembered the signs of pain and discomfort that prompted Gracies first stem cell therapy five years before.
Gracie was brought to Dr. Scavelli in 2008 with painful symptoms, and stem cell therapy for pets was the latest, cutting edge treatment. Gracies owners understood that without stem cell therapy Gracie would have faced hip surgery at the time.
We are grateful for stem cell therapy which has restored Gracies ability to enjoy her morning walks again, Mrs. Hamilton shared, She enjoys wrestling with us and playing with her toys. She looks forward to visiting her friends, and prances around like a puppy. Gracie is a happy dog and we are happy owners because she does not appear to be in pain anymore!
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.
Read the original:
Stem Cell Therapy by Vet-Stem, a Surprising Alternative to Hip Surgery for a New Jersey Chocolate Labrador Retriever
Patients who undergo experimental stem cell treatments run the risk of serious injury, Australian experts have warned.
A team of leading stem cell scientists say the treatments, which involve injecting patients with stem cells from their own fat deposits, have become available to Australian consumers without the protection of regulation or evidence of benefits.
Stem Cells Australia, a consortium of medical and scientific researchers from eight leading Australian universities and research institutes, raised concerns after it became clear the treatments, which are popular overseas, had spread to Australia.
They say vulnerable people with degenerative conditions, such as multiple sclerosis (MS) and Parkinson's disease, are being misled into paying up to $9,000 on stem cell therapies with little or no evidence of the benefits.
However, the industry says there is some good evidence available and treatments are safe as long as patients are only injected with their own unaltered cells.
Practising doctors are forming an industry group to write a code of conduct to keep patients safe.
In a submission to the National Health and Medical Research Council, Stem Cells Australia says many of the practices used by overseas doctors are now being witnessed among Australian practitioners.
These include direct-to-consumer marketing, using patient testimonials instead of evidence, offering the same treatments for unrelated illnesses, lack of safety evidence, no results in peer-reviewed journals, and hefty fees.
Program leader Professor Martin Pera says stem cell treatments are falling through a regulatory loophole because patients are treated with their own cells.
"What's going on is a large scale human experiment without proper scientific procedure and without proper regulatory oversight," he said.
Read more here:
Stem cell warning: experts fear experimental treatments will lead to serious injury
Shutdowns, lethal viruses, typhoons and meteorites much of this years science news seemed to come straight from the set of a Hollywood disaster movie. But there were plenty of feel-good moments, too. Space exploration hit a new high, cash poured in to investigate that most cryptic of human organs, the brain, and huge leaps were made in stem-cell therapies and the treatment of HIV. Here, captured in soundbites, statistics and summaries, is everything you need to know about the science that mattered in 2013.
LUX: Carlos H. Faham
The Large Underground Xenon dark-matter experiment, deep in a mine in South Dakota.
One of the years most important cosmological results was an experimental no-show. The Large Underground Xenon (LUX, pictured) experiment at Sanford Underground Research Facility in Lead, South Dakota 370 kilograms of liquid xenon almost 1.5kilometres down in a gold mine did not see any particles of elusive dark matter flying through Earth. But it put the tightest constraints yet on the mass of dark-matter particles, and their propensity to interact with visible matter. Theoretical physicist Matthew Strassler at Rutgers University in Piscataway, New Jersey, says a consensus is forming that hints of dark matter seen by earlier experiments in the past three years were probably just statistical fluctuations.
PlancK: ESA/Planck Collaboration
Whatever dark matter is, it makes up around 84% of the Universes total matter, according to observations, released in March, of the Universes cosmic microwave background (CMB) by the European Space Agencys Planck satellite. Plancks image (pictured) also strongly supports the hypothesis of inflation, in which the Universe is thought to have expanded rapidly after the Big Bang. A better probe of inflation might be provided through its predicted influence on how the polarization of CMB photons varies across the sky (B-mode polarization). That subtle signal has not been measured yet, but astronomers hopes were raised by news of the first sighting of a related polarization signal, by the South Pole Telescope, in July. And another Antarctic telescope the underground IceCube observatory confirmed this year that the high-energy neutrinos it has detected come from far away in the cosmos, hinting at a new world of neutrino astronomy.
Jae C. Hong/AP
US workers came out in force against the shutdown.
The slow decline of US federal support for research and development spending is already down 16.3% since 2010 reached a new nadir in October, when political brinkmanship led the government to shut down for 16 days. Grant money stopped flowing; work halted at major telescopes, US Antarctic bases and most federal laboratories; and key databases maintained by the government went offline. Many government researchers were declared non-essential and barred by law from visiting their offices and laboratories, or even checking their official e-mail accounts. Since the shutdowns end, grant backlogs and missed deadlines have scrambled agency workloads.
Away from the deadlock in the United States, the European Union negotiated a path to a 201420 research budget of almost 80billion (US$110billion), a 27% rise in real terms over the previous 200713 period. And funding in South Korea, China, Germany and Japan continued to increase (the United Kingdom and France saw little change). But Japans largesse came with the clear understanding that its science investment would bring fast commercial pay-offs. Along similar lines, US Republican politicians are calling for the National Science Foundation to justify every grant it awards as being in the national interest.
Link:
365 days: 2013 in review
DANIEL TOBIN/ Fairfax NZ
STEMMING PAIN: Lord Claude the st bernard was the first Christchurch dog to receive new stem cell treatment at Total Vets. Kirsten Wylie and Thea Sweeney inject stem cells to ease osteoarthritis in his hips and knees.
Christchurch pet owners have a new way to splash out on their pet care, with the arrival of stem cell treatment costing $2500.
The method uses stem cells from the animal's fat to inject into arthritic joints to relieve pain and limit the need for anti-inflammatories.
Tauranga veterinarian Gil Sinclair started using the technique in his clinic after learning about it in Australia, and has travelled the country helping other clinics set up laboratories.
On Tuesday, Sinclair was in Christchurch to help local clinic Total Vet with its first two patients, a kunekune pig named Samantha and a 78kg st bernard called Lord Claude.
Both animals suffer chronic osteoarthritis, and their respective owners made the leap in the hope of providing pain relief and greater joint use.
Total Vet owner Kirsten Wylie had been keen to get the new treatment in her clinic and approached Lord Claude's owners with the proposal to provide longer-term relief for his arthritis and hip dysplasia.
Stem cells were present throughout all body tissues, but were in particularly high concentration in bone marrow. Using bone marrow was difficult and time-consuming, as extractions had to be cultivated in a laboratory for several weeks to get enough to be useful.
The technique that Sinclair used could be completed in a day. In the morning the animal was brought in and blood and fat samples taken. Only a "heaped tablespoon" of fat was taken, and the stem cells removed and concentrated. Platelets from blood had high levels of naturally occurring stem cell activators, so these were added to the dormant stem cells to "wake" them up.
See the rest here:
New treatment eases pet pain